Genberg M, Öberg A, Andrén B, Hedenström H, Frisk P, Flachskampf F A
Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.
Pediatr Blood Cancer. 2015 Jan;62(1):143-7. doi: 10.1002/pbc.25135. Epub 2014 Sep 22.
Hematopoietic cell transplantation (HCT) including preparative regimens with chemotherapy and total body irradiation (TBI) is an accepted treatment for many malignant disorders but may have side-effects for several organs, including the cardiovascular system. The aim of this study was to study very long-term consequences on cardiac function after childhood HCT.
Cardiac function was evaluated using echocardiography and levels of NT-proBNP and growth hormone (GHmax) in 18 patients, at a median of 18 years after HCT including TBI, and in 18 matched controls.
Patients after HCT had cardiac dimensions, volumes, and left ventricular ejection fractions within normal range after correction for body size. However, compared with the control group, patients after HCT had significantly lower E/A ratio, as a measure of left ventricular diastolic function, significantly lower fractional shortening and mitral annular plane systolic excursion, as measures of left ventricular systolic function, significantly lower tricuspid annular plane systolic excursion, as a measure of right ventricular function, and significantly higher NT-proBNP, as a measure of total cardiac function. Also, pulmonary flow acceleration time was shorter in the group after HCT, indicating possible pulmonary involvement. Heart rate was significantly higher and GHmax significantly lower in patients after HCT.
Almost two decades after HCT, including preparative regimens with TBI, cardiac function in patients was found to be within normal range. However, when compared with a healthy control group, patients after HCT showed lower systolic and diastolic left ventricular function as well as lower right ventricular function.
造血细胞移植(HCT),包括采用化疗和全身照射(TBI)的预处理方案,是许多恶性疾病公认的治疗方法,但可能会对包括心血管系统在内的多个器官产生副作用。本研究的目的是探讨儿童期HCT后对心脏功能的长期影响。
对18例接受包括TBI的HCT后中位时间为18年的患者以及18例匹配的对照组,使用超声心动图评估心脏功能,并检测N末端脑钠肽前体(NT-proBNP)和生长激素水平(GHmax)。
校正身体大小后,HCT后的患者心脏尺寸、容积和左心室射血分数在正常范围内。然而,与对照组相比,HCT后的患者作为左心室舒张功能指标的E/A比值显著降低,作为左心室收缩功能指标的缩短分数和二尖瓣环平面收缩期位移显著降低,作为右心室功能指标的三尖瓣环平面收缩期位移显著降低,作为全心功能指标的NT-proBNP显著升高。此外,HCT组的肺血流加速时间较短,提示可能存在肺部受累。HCT后的患者心率显著较高,GHmax显著较低。
在包括采用TBI预处理方案的HCT后近二十年,发现患者的心脏功能在正常范围内。然而,与健康对照组相比,HCT后的患者左心室收缩和舒张功能以及右心室功能较低。